title: Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases.
abstract: Voriconazole is currently contraindicated for use with sirolimus. We report our experience with voriconazole/sirolimus in two renal transplant recipients. To our knowledge, this is the first experience with voriconazole/sirolimus. An interaction requiring a 75% to 87.5% sirolimus dose reduction was noted, but goal trough levels and clinical tolerability were achieved.
authors.affiliation: Department of Pharmacy, Saint Barnabas Medical Center, Livingston, New Jersey 07039, USA. smathis@sbhcs.com
authors.forename: A S
authors.initials: AS
authors.lastname: Mathis
authors.forename: N K
authors.initials: NK
authors.lastname: Shah
authors.forename: G S
authors.initials: GS
authors.lastname: Friedman
mesh_terms: D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy*; D001232:Aspergillus fumigatus; D002177:Candidiasis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008172:Lung Diseases, Fungal / Q000175:diagnosis*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000382:microbiology*; D011743:Pyrimidines / Q000627:therapeutic use*; D020123:Sirolimus / Q000627:therapeutic use*; D014230:Triazoles / Q000627:therapeutic use*; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D007166:Immunosuppressive Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole; D020123:Sirolimus